Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BMY - Geron: Pandemic And Legal Trials Cloud A Promising Clinical Trial

BMY - Geron: Pandemic And Legal Trials Cloud A Promising Clinical Trial

Bristol-Myers Squibb Company
  • Geron's only therapeutic candidate currently undergoing a Phase III trial has superior efficacy.
  • The consensus has underestimated its sales potential, and the shares have yet to reach the 2018 high.
  • Subject to regulatory approvals, a swift achievement of the fullest sales potential paints an attractive risk-reward opportunity.
  • Yet, with lawsuits hurting the financial outlook and the pandemic clouding the trial progress, we remain neutral on the stock.

For further details see:

Geron: Pandemic And Legal Trials Cloud A Promising Clinical Trial
Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...